GSK stock at EUR 22.64 ahead of Xetra open: drugmaker rises 0.40 percent

Published on 10/26/2026 at 07:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The company develops medicines and vaccines for human health. At Lang & Schwarz the stock trades pre-market at EUR 22.64 on October 26, 2026, 0.40 percent above the Xetra close of October 23, 2026.

Business model and market context

GSK develops medicines and vaccines for human health.
The home market is the United Kingdom, whose benchmark is the FTSE 100.
GSK stock trades pre-market at EUR 22.64 at 7:35 a.m. CET at Lang & Schwarz on October 26, 2026, 0.40 percent above the Xetra close of October 23, 2026.

Moderne Pharma-Produktionsanlage mit Glasfassade und Laboren bei Dämmerlicht — GSK plc (ISIN GB0009252882) betreibt moderne Pharmaanlagen mit Laboren und Produktionshallen in der Abenddämmerung, Illustration mit AI erstellt.

GSK develops medicines and vaccines for human health, according to its investor materials. At Lang & Schwarz, GSK stock trades pre-market at EUR 22.64 at 7:35 a.m. CET on October 26, 2026, 0.40 percent above the Xetra close of October 23, 2026 (EUR 22.55), based on the Xetra closing quote.

Ahead of the Xetra open

The pre-market indication is plus EUR 0.09 above the Xetra close. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of GSK stock.